Progress Through Disruptive Evolution.
Progress means making incremental improvements over time.
But the big ideas are disruptive and represent real breakthroughs that can bring significant advances to an industry.
Gestalt is committed to bringing anatomic pathology into the digital age.
We provide the enterprise solutions, and services, to transform anatomic pathology
laboratories from glass slides, microscopes and couriers to an automated, electronic
Our solution is geared toward laboratories of all sizes from the small independent facility to large integrated delivery networks. We include a universal digital viewer that allows images from different scanners to all be read in a single viewer. We have coupled this with an image acquisition capability that enables capture and transfer of very large digital image files. We can transfer a 40x resolution 500MB file from Delhi, India to the US in just 8 minutes compared to an unassisted non-Gestalt transfer time of over 8 hours using common file transfer methodologies. Whether you are working locally or globally – our platform provides the solid technical capabilities to bring your organization seamlessly and expeditiously into the digital age of healthcare. DELETE
Gestalt Diagnostics, LLC was formed as a joint-venture in 2015 that included Nuvodia, LLC (a subsidiary of Inland Imaging Investments, Inc.). Nuvodia provides PACS hosting and healthcare technology services to physicians, hospitals, clinics and laboratories across the United States and manages millions of medical imaging exams annually.
Gestalt Diagnostics has developed PathFlow, a software platform specifically designed to bring the benefits of digital workflow to pathologists and pathology laboratories. This product was originally developed, by what is now Gestalt’s team, to support Inland Imaging’s radiology practice as they evolved to a fully digital reading platform. Medicalis [Siemens Healthcare] acquired the rights to the intellectual property and has continued to expand the features and customer base nationally. Today it is used in leading hospitals across the United States and supports more than 13 million studies annually.